Yang, Yiqing

The cancer metabolic reprogramming and immune response

Xia, L., Oyang, L., Lin, J., Tan, S., Han, Y., Wu, N., Yi, P., Tang, L., Pan, Q., Rao, S., et al. (2021) · Molecular Cancer

Cancer, Hypoxia, and MetabolismImmune cells in cancer

Cited by 1,312

PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies

Sun, Y., Zhao, X., Ding, N., Gao, H., Wu, Y., Yang, Y., Zhao, M., Hwang, J., Song, Y., Liu, W., et al. (2018) · Cell Research

Protein Degradation and InhibitorsChronic Lymphocytic Leukemia Research

Cited by 295